In psoriasis patients, elevated IL-6 production in affected skin has been suggested to promote the differentiation of IL-17-producing pathogenic Th17 cells and reduce the suppressive capacity of Tregs, although this latter effect is likely to be indirect [35]. The gene discussed is IL17A; the disease is psoriasis.